SOMERVILLE, N.J., Nov. 18, 2010 /- Ethicon, Inc., a worldwide leader in surgical care, announced today that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human Fibrinogen and Human Thrombin), to aid in stoppi...

ethicon human application biologic fibrin license combines drug surgical administration submit food biologics leader thrombin care plasma submits padsomerville fibrinogen

LAGUNA NIGUEL, Calif., Nov. 19, 2010 /- Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced the Company has initiated treatment of patients in a pivotal clinical study of OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product, for the treatment of acquired hemophilia A, a rare, though potentially life-threatening bleeding disorder.  Based on a part...

inspiration acquir study pivotal hemophilia treatment alaguna threatening life company factor porcine calif initiate patients patient recombinant potentially rare intravenous

Almac and the Royal Society of Chemistry Host a Workshop on... -- CRAIGAVON, Northern Ireland, November 19, 2010 /-

workshop royal society chemistry host solid craigavon almac techniques formalmac northern november analytical monitor ireland

MINNEAPOLIS, Nov. 19, 2010 /- Uroplasty, Inc. (Nasdaq: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that Palmetto GBA for California, Nevada and Hawaii, a regional Medicare carrier, now covers posterior tibial nerve stimulation (PTNS) using the Urgent® PC Neuromodulation...

regional medicare carrier uroplasty neuromodulation urgent stimulation nerve ptns posterior tibial innovative manufactures company products additional deliver treat palmetto nasdaq

IRVINE, Calif., Nov. 19, 2010 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Piper Jaffray 22nd Annual Healthcare Conference at The New York Palace in New York City on Tuesday, November 30, at 12:30 p.m. ET.  A live audiocast of the presentation will be available on the Masimo website at www.masimo.com .  A replay of the aud...

masimo piper present healthcare york annual jaffray conference tuesday announc audiocast calif nasdaq schedul management masi replay city presentation november

COLUMBIA, S.C., Nov. 19, 2010 /PRNewswire-USNewswire/ -- Chemists at the University of South Carolina have developed a camera with the ability to see the invisible - and more. The new technology, called multimode imaging in the thermal infrared, could eventually be used in crime-scene investigations, since it can capture blood stains that the human eye can't see. Drs. Stephen Morgan and Mich...

multimode thermal usnewswire blood ability tool imaging visualize human technology mich invisible morgan chemistry south crime develop scene stephen researchers

BATESVILLE, Ind., Nov. 19, 2010 /- Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a management discussion at the 22nd Annual Piper Jaffray Health Care Conference in New York City on Tuesday, November 30, 2010, at 12 p.m. EST. You are invited to listen to the live discussion via the internet link at http://ir.hill-rom.com/events.cfm or access it direct...

hill listen health discussion jaffray care piper annual tuesday holdings november link invites direct city conference participate york internet events

MALVERN, Pa., Nov. 19, 2010 /- At the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 - December 2 in Chicago, Siemens Healthcare (Booth #822, East Building/Lakeside Center, Hall D) will unveil the Biograph™ mMR*, the world's first integrated whole-body molecular Magnetic Resonance (MR) system with simultaneous data...

data whole biograph simultaneous siemens body integrate december healthcare east building world radiological chicago assembly rsna america molecular resonance unveil

BOULDER, Colo., Nov. 19, 2010 /- With the European Union poised to regulate probiotics, and with probiotic supplement sales increasing dramatically in the United States, Americans need to know what they're buying, and how these products can affect their health. "Currently, there are not these types of regulations in the U.S. As European regulations raise the bar in the probiotic...

regulations probiotics americans european probiotic products supplement states union health dramatically pois types regulate unit europe increasing raise buyingboulder sales

NEW YORK, Nov. 19, 2010 /- Pfizer Inc. (NYSE: PFE ) announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival (PFS) when compared to sorafen...

axitinib trial phase patients pfizer previously metastatic mrcc renal cell treate carcinoma significantly nyse survival extend endpoint sorafen announc compar

BROOMFIELD, Colo., Nov. 19, 2010 /- Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer (NSCLC) were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Cent...

cancer lung combination patients veristrat aacr held line advanc erlotinib egbert medical present nsclc test cell trial sorafenib targets symposium

ORLANDO, Fla., Nov. 19, 2010 /- Schizophrenia is a chronic and disabling brain disorder that affects 1 percent of the U.S. population and results in substantial medical and societal costs, in particular from use of health-care resources. It also can have devastating health-related and social effects on people with the disease, their families and caregivers. A pre-specified analysi...

health schizophrenia substantial chronic costs caregivers suggests decreas adults resources people family social longer percent treate analysi hospitalization term rates

WOONSOCKET, R.I., Nov. 19, 2010 /- CVS Caremark's (NYSE: CVS ) Pharmacy Benefit Management Customer Care team was ranked second in the world for Best Customer Service with an Internal Contact Center by Contact Center World at the organization's Global Top Ranking Performers Awards Conference in Las Vegas.  The awards recognize the best in the contact center industry worldwi...

center customer contact world ranking awards global team performers caremark service care recognize internal silver medal organization nyse second benefit

SAN MATEO, Calif., Nov. 19, 2010 /- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced that the Centers for Medicare and Medicaid Services (CMS) has granted a unique, Level II Health Care Common Procedural Coding System (Level II HCPCS), commonly referred to as a J-code, for Qutenz...

neurogesx level code medicaid centers services medicare developing refer calif ngsx qutenz unique pain coding care mateo health qutenza grant

SAN DIEGO, Nov. 19, 2010 /- Marshall Edwards, Inc.(Nasdaq: MSHL ), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that it was notified on November 16, 2010 by the Listing Qualifications Staff of The NASDAQ Stock Market that, due to the Company's non-compliance with the minimum $10 million stockholders' equity re...

nasdaq marshall compliance company edwards focus minimum anti novel qualifications million market announc cancer mshl stock hearingsan notified development stockholders

PLYMOUTH MEETING, Pa., Nov. 19, 2010 /PRNewswire-USNewswire/ -- ECRI Institute Patient Safety Organization (PSO) today announces an agreement to provide patient safety services to the Tennessee Center for Patient Safety established by the Tennessee Hospital Association. ECRI Institute PSO will support the Tennessee Center for Patient Safety with a patient safety data collection and reporting s...

patient safety tennessee ecri institute hospital center association collection chosen reporting agreement organization data establish prnewswire services provide usnewswire meeting

BOSTON, Nov. 19, 2010 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company's management has approved its 2011 recapitalization plan in order to position itself for growth over the next twelve months. The recapitalization plan is designed to increase financial flexibility for Solos and its shareholders. The recapitalization plan allows S...

plan solos endoscopy allows next order months position financial increase flexibility sndy shareholders twelve management pink sheets growth announce design

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation. (Logo:   http://photos.prnewswire....

bone relate cancer xgeva help events prnewswire prevent skeletal patients spread requiring administration injurysilver drug fractures photos food logo approv

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- Xanodyne Pharmaceuticals Inc., which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration. The FDA has also informed generic manufacturers of Xanodyne's decision and they will...

xanodyne medication propoxyphene inform makes pharmaceuticals prnewswire brand darvocet darvon prescription pain drug spring withdraw agree administration food usnewswire generic

PaedRegCliNet e.V.: A Boost for Safe Pediatric Medications -- MUNICH, November 19, 2010 /-

safe boost pediatric paedregclinet munich medications november